Domperidone Alert

On June 7, 2004, the FDA issued a warning against the use of domperidone.

This warning came as a shock to most of us in the lactation community and there has been much discussion about it. On this page you will find links to information on this controversy.

The Adverse reactions that the FDA refers to were with IV usage, mostly high dose, and in patients who were already sick , i.e. with cancer. No arrhythmias or deaths have been reported from the oral dose in the healthy population.

It is also interesting to note that this warning came out just days after the The U.S. Department of Health and Human Services’ Office on Women’s Health (OWH) and the Advertising Council announced the launch of a new national campaign that encourages first-time mothers to breastfeed exclusively for six months. “Babies were born to be breastfed,” is the theme.

For more information, see

FDA Talk Paper

FDA warnings

FDA How to Obtain

Official Statements from Prominent Physicians:

  • Jack Newman
  • Jay Gordon
  • Frank Nice

FDA Talk Paper

FDA Warning on Domperidone Conference Call June 7 -11, 2004

AAP - The Transfer of Drugs and Other Chemicals Into Human Milk Table 6 lists Domperidone as Usually Compatible With Breastfeeding

Petition to get Domperidone Approved

Breastfeedingonline adheres to the
WHO International Code of Marketing of Breast Milk Substitutes
& the WHO/UNICEF Baby Friendly Hospital Initiative